BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sucher E, Sucher R, Gradistanac T, Brandacher G, Schneeberger S, Berg T. Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies. J Immunol Res 2019;2019:9437043. [PMID: 31886312 DOI: 10.1155/2019/9437043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Barba Bernal R, Medina-morales E, Goyes D, Patwardhan V, Bonder A. Management of Autoimmune Liver Diseases after Liver Transplantation. Transplantology 2021;2:162-82. [DOI: 10.3390/transplantology2020016] [Reference Citation Analysis]
2 Zhang X, Thompkins-Johns A, Ziober A, Zhang PJ, Furth EE. Hepatic Macrophage Types Cluster with Disease Etiology in Chronic Liver Disease and Differ Compared to Normal Liver: Implications for Their Biologic and Diagnostic Role. Int J Surg Pathol 2022;:10668969221099630. [PMID: 35521912 DOI: 10.1177/10668969221099630] [Reference Citation Analysis]
3 Gökbulut V, Öztürk Ö, Akdoğan Kayhan M, Kaplan M, Kacar S, Sümer H, Gökbulut P, Ari D, Turan Gökçe D. Evaluation of esophageal motor functions in patients diagnosed with primary biliary cholangitis, primary sclerosing cholangitis and autoimmune hepatitis. Cukurova Medical Journal 2022;47:21-8. [DOI: 10.17826/cumj.984551] [Reference Citation Analysis]
4 Hagiwara S, Watanabe T, Kudo M, Minaga K, Komeda Y, Kamata K, Kimura M, Hayashi H, Nakagawa K, Ueshima K, Minami Y, Aoki T, Takita M, Morita M, Cishina H, Ida H, Park AM, Nishida N. Clinicopathological analysis of hepatic immune-related adverse events in comparison with autoimmune hepatitis and graft-versus host disease. Sci Rep 2021;11:9242. [PMID: 33927311 DOI: 10.1038/s41598-021-88824-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li SS, Niu M, Jing J, Huang Y, Zhang ZT, Chen SS, Shi GZ, He X, Zhang HZ, Xiao XH, Zou ZS, Yu YC, Wang JB. Metabolomic Signatures of Autoimmune Hepatitis in the Development of Cirrhosis. Front Med (Lausanne) 2021;8:644376. [PMID: 33777984 DOI: 10.3389/fmed.2021.644376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Xue M, Shen Y, Fan X, Shen M, Yang L. Autoimmune Hepatitis with Elevated Serum IgG4 Levels Have a High Prevalence of Cirrhosis at Diagnosis.Can J Gastroenterol Hepatol. 2021;2021:6692511. [PMID: 33489994 DOI: 10.1155/2021/6692511] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Fan JH, Liu GF, Lv XD, Zeng RZ, Zhan LL, Lv XP. Pathogenesis of autoimmune hepatitis. World J Hepatol 2021; 13(8): 879-886 [PMID: 34552694 DOI: 10.4254/wjh.v13.i8.879] [Reference Citation Analysis]
8 Hao J, Sun W, Xu H. Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice. Int Immunopharmacol 2022;102:108411. [PMID: 34891001 DOI: 10.1016/j.intimp.2021.108411] [Reference Citation Analysis]
9 Capra AP, Chiara E, Briuglia S. Autoimmune hepatitis in genetic syndromes: A literature review. World J Hepatol 2021; 13(10): 1328-1340 [PMID: 34786169 DOI: 10.4254/wjh.v13.i10.1328] [Reference Citation Analysis]
10 Mukherjee S, Kar A, Khatun N, Datta P, Biswas A, Barik S. Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures. Cells 2021;10:1917. [PMID: 34440687 DOI: 10.3390/cells10081917] [Reference Citation Analysis]
11 Çavuş B, Akyuz F, İliaz R, Atasoy A, Akyuz U, Demir K, Besisik F, Kaymakoglu S. Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life? Int J Immunopathol Pharmacol 2022;36:3946320221077860. [PMID: 35171719 DOI: 10.1177/03946320221077860] [Reference Citation Analysis]
12 Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv Cancer Res 2021;149:1-61. [PMID: 33579421 DOI: 10.1016/bs.acr.2020.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
13 Abbas Z, Asim M, Saeed A, Siddiqui B, Abbas M. The Spectrum of Autoimmune Liver Disorders, Clinical Presentation, and Autoantibodies in Patients From a Tertiary Care Center in Pakistan. Cureus 2021;13:e19789. [PMID: 34820249 DOI: 10.7759/cureus.19789] [Reference Citation Analysis]
14 Kunovsky L, Dite P, Jabandziev P, Kala Z, Vaculova J, Andrasina T, Hrunka M, Bojkova M, Trna J. Autoimmune Diseases of Digestive Organs-A Multidisciplinary Challenge: A Focus on Hepatopancreatobiliary Manifestation. J Clin Med 2021;10:5796. [PMID: 34945093 DOI: 10.3390/jcm10245796] [Reference Citation Analysis]
15 Vogelbacher L, Thimme R, Böttler T. [Autoimmune Hepatitis - What is important for clinical practice?]. Dtsch Med Wochenschr 2022;147:470-80. [PMID: 35405751 DOI: 10.1055/a-1520-4214] [Reference Citation Analysis]
16 Ramachandran A, Antala D, Pudasainee P, Panginikkod S, Gupta H. A Plausible Association Between the Use of Elderberry and Autoimmune Hepatitis. Cureus. [DOI: 10.7759/cureus.24250] [Reference Citation Analysis]
17 Chen S, Zhu JY, Zang X, Zhai YZ. The Emerging Role of Ferroptosis in Liver Diseases. Front Cell Dev Biol 2021;9:801365. [PMID: 34970553 DOI: 10.3389/fcell.2021.801365] [Reference Citation Analysis]